Navigation Links
Taxus VI Clinical Trial Demonstrates Positive Long-Term Outcomes,for Moderate-Release Paclitaxel-Eluting Stent at Four Years

ntrolled study of 446 patients at 44 international sites is designed to assess the TAXUS moderate-release paclitaxel-eluting coronary stent system in reducing restenosis in high-risk patients, including de novo lesions with overlapping stents, lesions 26 mm or greater in length and small vessels. Lesion size ranged from 18 - 40 mm in length and 2.5 - 3.75 mm in diameter. TAXUS VI is the first randomized, controlled clinical trial to demonstrate durability of drug-eluting stents in complex lesions at four years. Follow-up included 98 percent of the patients enrolled at four years.

The study's results demonstrate a continued significant reduction in target lesion revascularization (TLR, or retreatment rate) as compared to the bare-metal stent control group at four years. The four-year TLR rate was 12.9 percent for the TAXUS Stent group, as compared with 21.4 percent for the control group (P=0.0082 (only two TLR events were reported between three and four years for the TAXUS Stent group)). The rate of patients living free of TLR events was 87.1 percent at four years for the TAXUS Stent group, as compared to 78.6 percent for the bare-metal stent control group.

The four-year results for TAXUS VI support long-term safety with the increased levels of paclitaxel in the moderate-release formulation used in the study. Even with an in vitro dosing rate 8-10 times greater than the commercialized slow-release formulation, no compromise in safety was observed. The TAXUS Stent group continues to report no new stent thrombosis after two years with a low 2.4 percent cardiac death rate.

Boston Scientific launched the slow-release formulation TAXUS Express2 paclitaxel-eluting coronary stent system in Europe and other international markets in 2003 and in the United States in 2004. The Company launched the slow-release formulation TAXUS(R) Liberte(TM) paclitaxel-eluting coronary stent system in Europe and other international markets in 2005. The TAXUS Express modera
'"/>




Page: 1 2 3

Related medicine technology :

1. New Study Suggests Better Patient Outcomes with CYPHER Sirolimus-Eluting Coronary Stent than with Taxus Stent in Real-World Clinical Settings
2. Positive Results for Second-Generation Taxus Liberte Coronary Stent System Highlighted in Journal of American College of Cardiology
3. SPIRIT Clinical Data Reaffirm Strength of Taxus and Promus Drug-Eluting Coronary Stent Systems
4. Abbotts Xience V Everolimus Eluting Coronary Stent Superior to Taxus Stent in Spirit III U.S. Pivotal Clinical Trial
5. Genetic Analysis Systems Enter the Clinical Mainstream
6. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
7. Large Geographic Differences in EpiPen Prescriptions in the U.S., From the Journal of Allergy and Clinical Immunology
8. Clinical Data Suggest Decreased Bleeding Risk in People With Severe Hemophilia A While Maintaining Factor VIII Levels Above One Percent
9. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
10. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
11. Corgenix Reports New Clinical Data Correlating AtherOx Technology With Vascular Disease
Post Your Comments:
(Date:7/24/2014)... MENLO PARK, Calif. , July 24, 2014 ... announced today that the company,s board of directors approved a ... June 30. Accordingly, DelMar will file a Transition Form 10K ... Bacha , president and CEO of DelMar stated, "The change ... our goal of obtaining a senior exchange listing for our ...
(Date:7/24/2014)... N.C. , July 24, 2014 ... has signed an Agreement with Kineticos, a ... consulting company. Kineticos will support LSI Medience in ... sepsis management, to demonstrate utility in clinical trials. ... shown potential utility in diagnosis of sepsis, prognosis ...
(Date:7/24/2014)... , July 24, 2014 Talyst, a market ... 2014 National Association of State Veterans Homes (NASVH) Summer ... The goal of the NASVH is to ensure that ... services, long term health care and respect which they ... With the InSite® Remote Dispensing System, Talyst can ...
Breaking Medicine Technology:DelMar Pharmaceuticals Announces Change of Fiscal Year End and Provides Update on Glioblastoma Clinical Trial 2DelMar Pharmaceuticals Announces Change of Fiscal Year End and Provides Update on Glioblastoma Clinical Trial 3LSI Medience Corporation and Kineticos Sign Agreement Related to the Presepsin Biomarker in Sepsis Management and Treatment 2Talyst Exhibits at the National Association of State Veterans Homes Summer Conference 2
... 1, 2011 Reportlinker.com announces that a ... its catalogue: Dry Powder ... http://www.reportlinker.com/p0581176/Dry-Powder-Inhalation-Devices-Drugs-Therapeutics-Markets-and-Forecasts ... formulation and inhalation device design are creating ...
... 1, 2011 Reportlinker.com announces that a ... its catalogue: Insulin- Global ... This package contains 63 insulin market ... Bulgaria, Czech Republic,Denmark, Estonia, Finland, France, Germany, ...
Cached Medicine Technology:Dry Powder Inhalation: Devices, Drugs, Therapeutics, Markets and Forecasts 2Dry Powder Inhalation: Devices, Drugs, Therapeutics, Markets and Forecasts 3Insulin- Global 2
(Date:7/24/2014)... Doheny HealthDay Reporter THURSDAY, ... often don,t view their kids as unhealthy or recognize the ... new study. The children of the families surveyed for ... Hasbro Children,s Hospital in Providence, R.I. "A third categorized ... researcher Dr. Kyung Rhee, now an assistant professor of pediatrics ...
(Date:7/24/2014)... researchers may have found a way to delay or ... of neurons with the anti-aging protein Klotho can prevent ... protein and glutamate. These findings currently appear in the ... disease is the most frequent age-related dementia affecting 5.4 ... and older and more than 40 percent of people ...
(Date:7/24/2014)... SHAWNEE, Kan. (PRWEB) July 24, 2014 ... announces that it has achieved certification for ... as tested and verified by the DoD Information ... Acuo Vendor Neutral Archive, identified within the DoD ... the Authority to Operate designation from the U.S. ...
(Date:7/24/2014)... equally positive outcomes experience paradoxical feelings of pleasure ... regions of the brain, according to research led ... the Princeton Neuroscience Institute at Princeton University. ... desirability of more than 300 products using an ... paired products with different or similar values and ...
(Date:7/24/2014)... 2014 Horizon BCBSNJ’s second annual “Back ... family a rent-free week in a beautiful Lavallette shore ... Don’t miss your chance to win a week’s vacation ... all New Jersey residents, 25 or older.* Residents can ... http://www.facebook.com/HorizonBCBSNJ . , “A family vacation at the ...
Breaking Medicine News(10 mins):Health News:Parents of Obese Kids Often View Them as Healthy 2Health News:Parents of Obese Kids Often View Them as Healthy 3Health News:BU researchers discover that Klotho is neuroprotective against Alzheimer's disease 2Health News:Perceptive Software Achieves DIACAP Certification for Vendor Neutral Archive Solution to Support U.S. Department of Defense Integrated Clinical Systems Program 2Health News:Perceptive Software Achieves DIACAP Certification for Vendor Neutral Archive Solution to Support U.S. Department of Defense Integrated Clinical Systems Program 3Health News:Perceptive Software Achieves DIACAP Certification for Vendor Neutral Archive Solution to Support U.S. Department of Defense Integrated Clinical Systems Program 4Health News:Brain's dynamic duel underlies win-win choices 2Health News:Brain's dynamic duel underlies win-win choices 3Health News:(Beach) Sands of Time Running out to Enter Horizon Blue Cross Blue Shield of New Jersey’s 2014 “Back to the Boardwalk” Sweepstakes 2
... healthcare grade televisions and on-demand patient and staff interactive education ... education and entertainment system into Timpanogos Regional Hospital in Orem, ... ... Raleigh, NC (Vocus) May 20, 2009 -- TeleHealth Services ...
... and nerve damage , , WEDNESDAY, May 20 (HealthDay News) -- ... their blood glucose levels at a normal, low level. ... when it comes to avoiding the complications of the disease, ... Diabetes is a disease in which the body does not ...
... Minn., May 20 Orasi Medical, Inc. announced today ... financing round.The company will use this capital to expand ... the pharmaceutical and clinical markets. Pharmaceutical companies will use ... to treat various neurological diseases. Orasi is currently in ...
... Side discrepancy errors in radiology reports do occur and ... communicate well to help prevent errors in clinical management, ... Boston, MA. "Side discrepancy errors refer to instances when ... one or more sections of the radiology report," said ...
... Hard to Treat Diseases, Inc. (HTDS:PK) http://www.htdsmedical.com reports ... of some significant new advances recently announced regarding the ... are currently conducting research. , On Wednesday, May 13, ... A ground-breaking Canada-wide clinical ...
... St. Cloud Orthopedic Associates (SCOA), the largest orthopedic physician ... chosen to partner with the St. Cloud Surgical Center, ... a group of local physicians. SCA is a leading ... allow St. Cloud Surgical Center, which has provided high ...
Cached Medicine News:Health News:TeleHealth Services chosen by HCA to Install Interactive Patient Education System in Timpanogos Regional Hospital 2Health News:TeleHealth Services chosen by HCA to Install Interactive Patient Education System in Timpanogos Regional Hospital 3Health News:TeleHealth Services chosen by HCA to Install Interactive Patient Education System in Timpanogos Regional Hospital 4Health News:Glucose Control Pays Long-Term Benefits for Diabetics 2Health News:Hard to Treat Diseases, Inc. (HTDS) Reports on New Uses For Ribavirin 2Health News:Hard to Treat Diseases, Inc. (HTDS) Reports on New Uses For Ribavirin 3Health News:St. Cloud Orthopedic Associates to Partner with Surgical Care Affiliates 2
... Used retrograde to ... establish a Peel-Away ureteral ... The temporary protective Peel-Away ... away as the ureteroscope ...
Radiopaque markers are placed at the proximal and distal ends of the balloon. A special pin vise handle is included to stabilize the wire guide during introduction. Supplied sterile in peel-open pack...
... design allows the ureter to be dilated ... at the base of the balloon allows ... dilation. Supplied sterile in peel-open packages. Intended ... Handle (plastic), Straight Safety Wire Guide [.038 ...
... Fr Straight Channel; 33 or 42 cm ... Operating Ureteroscopes offer a small distal diameter ... to the ureter for diagnosis and treatment. ... ideal for large operating instruments, mechanical (Lithoclast) ...
Medicine Products: